CinvantiActive Ingredient(s): Aprepitant
FDA Approved: * November 9, 2017
Pharm Company: * HERON THERAPS INC
Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting. It may be used together with ondansetron and dexamethasone. It is taken by mouth. Common side effects include tiredness, loss of appetite, diarrhea, abdominal pain, hiccups, itchiness, pneumonia, and blood pressure changes. Other sev... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.